Raleigh, NC, United States of America

Scott Lyman

USPTO Granted Patents = 5 

Average Co-Inventor Count = 2.7

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2023-2025

Loading Chart...
5 patents (USPTO):Explore Patents

Title: Scott Lyman: Innovator in Dry Powder Formulations

Introduction

Scott Lyman is a notable inventor based in Raleigh, NC, who has made significant contributions to the field of pharmaceutical formulations. With a total of five patents to his name, Lyman has focused on developing innovative solutions for critical medical conditions.

Latest Patents

Among his latest patents, Lyman has developed dry powder formulations of epinephrine. These formulations are designed for nasal application and include epinephrine alone or in combination with at least one enabling agent. The unit dose forms and devices created from these formulations are intended for the treatment of various conditions, including anaphylaxis, anaphylactoid reactions, respiratory conditions, hemodynamic collapse, and for administration during cardiopulmonary arrest and other life-threatening situations.

Career Highlights

Lyman's career is marked by his dedication to advancing medical treatments through innovative formulations. His work has the potential to improve patient outcomes in emergency situations, showcasing his commitment to public health.

Collaborations

Throughout his career, Lyman has collaborated with notable colleagues, including Barry Bleske and Ted William Lanpher. These partnerships have contributed to the development and refinement of his innovative formulations.

Conclusion

Scott Lyman's contributions to the field of pharmaceutical innovations, particularly in dry powder formulations of epinephrine, highlight his role as a significant inventor. His work continues to pave the way for advancements in emergency medical treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…